טוען...
A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis
Tosufloxacin, which is not used to treat Mycobacterium tuberculosis, is a fluoroquinolone recommended for pneumonia when the possibility of tuberculosis infection cannot be excluded. In the present case, symptoms and chest infiltrative shadow initially improved by tosufloxacin. Therefore, we regarde...
שמור ב:
| הוצא לאור ב: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Japanese Society of Internal Medicine
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378169/ https://ncbi.nlm.nih.gov/pubmed/30643085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1369-18 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|